These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 16820217

  • 1. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
    Caporale CM, Papola F, Fioroni MA, Aureli A, Giovannini A, Notturno F, Adorno D, Caporale V, Uncini A.
    J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms.
    Kuijf ML, Geleijns K, Ennaji N, van Rijs W, van Doorn PA, Jacobs BC.
    J Neuroimmunol; 2008 Dec 15; 205(1-2):110-2. PubMed ID: 18838176
    [Abstract] [Full Text] [Related]

  • 3. Polymorphisms of CD1 genes in chronic dysimmune neuropathies.
    De Angelis MV, Notturno F, Caporale CM, Pace M, Uncini A.
    J Neuroimmunol; 2007 May 15; 186(1-2):161-3. PubMed ID: 17428545
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain-Barré syndrome.
    Liu H, Xing Y, Guo Y, Liu P, Zhang H, Xue B, Shou J, Qian J, Peng J, Wang R, Gao Y, Fang S.
    J Neurol Sci; 2016 Oct 15; 369():39-42. PubMed ID: 27653862
    [Abstract] [Full Text] [Related]

  • 5. CD1A and CD1E gene polymorphisms are not associated with susceptibility to Guillain-Barré syndrome in the Bangladeshi population.
    Rahman MI, Jahan I, Khalid MM, Jahan I, Ahammad RU, Nahar S, Islam Z.
    J Neuroimmunol; 2018 Jan 15; 314():8-12. PubMed ID: 29301656
    [Abstract] [Full Text] [Related]

  • 6. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
    Geleijns K, Jacobs BC, Van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA.
    J Neuroimmunol; 2004 May 15; 150(1-2):132-8. PubMed ID: 15081257
    [Abstract] [Full Text] [Related]

  • 7. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M, Takahashi M, Masuda M, Hirata K, Yuki N.
    Neurology; 2005 Nov 08; 65(9):1376-81. PubMed ID: 16162859
    [Abstract] [Full Text] [Related]

  • 8. Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population.
    Nyati KK, Prasad KN, Verma A, Singh AK, Rizwan A, Sinha S, Paliwal VK, Pradhan S.
    J Neuroimmunol; 2010 Jan 25; 218(1-2):116-9. PubMed ID: 19913922
    [Abstract] [Full Text] [Related]

  • 9. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K, Koga M, Takahashi M, Hirata K, Yuki N.
    J Neurol Sci; 2006 Jul 15; 246(1-2):163-8. PubMed ID: 16600306
    [Abstract] [Full Text] [Related]

  • 10. The effect of TNF-alpha, FcγR and CD1 polymorphisms on Guillain-Barré syndrome risk: evidences from a meta-analysis.
    Wu LY, Zhou Y, Qin C, Hu BL.
    J Neuroimmunol; 2012 Feb 29; 243(1-2):18-24. PubMed ID: 22236374
    [Abstract] [Full Text] [Related]

  • 11. HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.
    Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA.
    Neurology; 2005 Jan 11; 64(1):44-9. PubMed ID: 15642902
    [Abstract] [Full Text] [Related]

  • 12. Polymorphism of CD1 and SH2D2A genes in inflammatory neuropathies.
    Uncini A, Notturno F, Pace M, Caporale CM.
    J Peripher Nerv Syst; 2011 Jun 11; 16 Suppl 1():48-51. PubMed ID: 21696499
    [Abstract] [Full Text] [Related]

  • 13. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K, Yuki N.
    J Infect Dis; 2006 Feb 15; 193(4):547-55. PubMed ID: 16425134
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K, Koga M, Odaka M, Hirata K, Takahashi M, Li J, Gilbert M, Yuki N.
    Neurology; 2006 Nov 28; 67(10):1837-43. PubMed ID: 17130419
    [Abstract] [Full Text] [Related]

  • 16. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N.
    Ann Neurol; 2000 Oct 28; 48(4):624-31. PubMed ID: 11026446
    [Abstract] [Full Text] [Related]

  • 17. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.
    Ann Biol Clin (Paris); 2002 Oct 28; 60(5):589-97. PubMed ID: 12368145
    [Abstract] [Full Text] [Related]

  • 18. Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome.
    Geleijns K, Emonts M, Laman JD, van Rijs W, van Doorn PA, Hermans PW, Jacobs BC.
    J Neuroimmunol; 2007 Oct 28; 190(1-2):127-30. PubMed ID: 17761309
    [Abstract] [Full Text] [Related]

  • 19. Polymorphism of human CD1 genes.
    Han M, Hannick LI, DiBrino M, Robinson MA.
    Tissue Antigens; 1999 Aug 28; 54(2):122-7. PubMed ID: 10488738
    [Abstract] [Full Text] [Related]

  • 20. Association of CD1 and FcγR gene polymorphisms with Guillain-Barré syndrome susceptibility: a meta-analysis.
    Zhang L, Liu L, Li H, Guo L, Yu Q, Teng J.
    Neurol Sci; 2018 Dec 28; 39(12):2141-2149. PubMed ID: 30232664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.